Abstract: A novel organic compound is provided. The organic compound is represented by General Formula (G1).

Abstract: A novel compound is provided. The compound is represented by General Formula (G1). In General formula (G1), each of Z1 to Z4 independently has a structure represented by General formula (Z-1) or General formula (Z-2). In General Formula (Z-1), each of X1 and X2 independently represents any one of an alkyl group having 3 to 10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 10 carbon atoms, a cycloalkyl group with a bridge structure having 7 to 10 carbon atoms, and a trialkylsilyl group having 3 to 12 carbon atoms. Moreover, each of Ar1 and Ar2 independently represents an aromatic hydrocarbon group having 6 to 13 carbon atoms, and at least one of Ar1 and Ar2 includes a substituent that is the same as X1.

Abstract: An organic compound has a benzonaphthofuran skeleton and is represented by General Formula (G1). In General Formula (G1), A represents a pyrene skeleton. In the case where the pyrene skeleton has a substituent, the substituent is a diarylamino group including two substituted or unsubstituted aryl groups each having 6 to 13 carbon atoms, a substituted or unsubstituted aryl group having 6 to 13 carbon atoms, an alkyl group having 1 to 7 carbon atoms, a substituted or unsubstituted monocyclic saturated hydrocarbon group having 3 to 20 carbon atoms, or a substituted or unsubstituted polycyclic saturated hydrocarbon group having 7 to 10 carbon atoms. The two aryl groups of the diarylamino group may be the same or different.

Abstract: A novel organic compound that is highly convenient, useful, or reliable is provided. The organic compound is represented by General Formula (G1). Note that at least one of R1 to R26 represents deuterium. At least one of R1 to R7 represents any one of an alkyl group, a cycloalkyl group, a trialkylsilyl group, and an aryl group. The others of R1 to R7 each independently represent any one of hydrogen, an alkyl group, a cycloalkyl group, a trialkylsilyl group, and an aryl group. R8 to R26 each independently represent any one of hydrogen, an alkyl group, a cycloalkyl group, a trialkylsilyl group, and an aryl group. The alkyl group has 3 to 10 carbon atoms, the cycloalkyl group has 3 to 10 carbon atoms, the trialkylsilyl group has 3 to 12 carbon atoms, and the aryl group has 6 to 25 carbon atoms.

Abstract: A novel compound represented by formula (G1) is provided. In formula (G1), A represents a substituted or unsubstituted condensed aromatic ring having 10 to 30 carbon atoms or a substituted or unsubstituted condensed heteroaromatic ring having 10 to 30 carbon atoms, and Z1 to Z3 each independently have a structure represented by formula (Z-1) or (Z-2). In formula (Z-1), X1 and X2 each independently represent any one of an alkyl group having 3 to 10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 10 carbon atoms, a cycloalkyl group having a bridge structure and having 7 to 10 carbon atoms, and a trialkylsilyl group having 3 to 12 carbon atoms. In addition, Ar1 to Ar4 each independently represent a substituted or unsubstituted aromatic hydrocarbon group having 6 to 13 carbon atoms, and at least one of Ar1 to Ar4 has the same substituent as X1 or X2.

Abstract: An organic compound has a benzonaphthofuran skeleton and is represented by General Formula (G1). In General Formula (G1), A represents a pyrene skeleton. In the case where the pyrene skeleton has a substituent, the substituent is a diarylamino group including two substituted or unsubstituted aryl groups each having 6 to 13 carbon atoms, a substituted or unsubstituted aryl group having 6 to 13 carbon atoms, an alkyl group having 1 to 7 carbon atoms, a substituted or unsubstituted monocyclic saturated hydrocarbon group having 3 to 20 carbon atoms, or a substituted or unsubstituted polycyclic saturated hydrocarbon group having 7 to 10 carbon atoms. The two aryl groups of the diarylamino group may be the same or different.

Abstract: A novel compound is provided. The novel compound is represented by General Formula (G1). Each of A1 and A2 independently represents a substituted or unsubstituted condensed aromatic ring, a substituted or unsubstituted condensed heteroaromatic ring, or a structure represented by Formula (Z-1) or (Z-2); and each of Z1 and Z2 independently has a structure represented by Formula (Z-1) or (Z-2). Each of X1 and X2 independently represents any one of an alkyl group, a cycloalkyl group, a substituted or unsubstituted cycloalkyl group having a bridge structure, and a trialkylsilyl group. Each of Ar1 and Ar2 independently represents a substituted or unsubstituted aromatic hydrocarbon group, and at least one of Ar1 and Ar2 includes the same substituent as X1. Each of R1 to R16 independently represents any one of hydrogen, an alkyl group, a substituted or unsubstituted cycloalkyl group, a trialkylsilyl group, and a substituted or unsubstituted aryl group.

Abstract: A novel compound represented by formula (G1) is provided. In formula (G1), A represents a substituted or unsubstituted condensed aromatic ring having 10 to 30 carbon atoms or a substituted or unsubstituted condensed heteroaromatic ring having 10 to 30 carbon atoms, and Z1 to Z3 each independently have a structure represented by formula (Z-1) or (Z-2). In formula (Z-1), X1 and X2 each independently represent any one of an alkyl group having 3 to 10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 10 carbon atoms, a cycloalkyl group having a bridge structure and having 7 to 10 carbon atoms, and a trialkylsilyl group having 3 to 12 carbon atoms. In addition, Ar1 to Ar4 each independently represent a substituted or unsubstituted aromatic hydrocarbon group having 6 to 13 carbon atoms, and at least one of Ar1 to Ar4 has the same substituent as X1 or X2.

Abstract: A novel compound is provided. The novel compound is represented by General Formula (G1). In General Formula (G1), A represents a substituted or unsubstituted condensed aromatic ring having 10 to 30 carbon atoms or a substituted or unsubstituted condensed heteroaromatic ring having 10 to 30 carbon atoms, and R1 represents a substituted or unsubstituted aryl group having 6 to 25 carbon atoms. Each of Y1 and Y2 independently represents a cycloalkyl group having a bridge structure and having 7 to 10 carbon atoms.

Abstract: A light-emitting element with high emission efficiency and high reliability is provided. The light-emitting element includes a host material and a guest material in a light-emitting layer. The host material has a function of converting triplet excitation energy into light emission and the guest material emits fluorescence. The molecular structure of the guest material is a structure including a luminophore and protecting groups, and five or more protecting groups are included in one molecule of the guest material. The introduction of the protecting groups into the molecule inhibits energy transfer of triplet excitation energy by the Dexter mechanism from the host material to the guest material. As the protecting group, an alkyl group or a branched-chain alkyl group is used.

Abstract: An organic compound has a benzonaphthofuran skeleton and is represented by General Formula (G1). In General Formula (G1), A represents a pyrene skeleton. In the case where the pyrene skeleton has a substituent, the substituent is a diarylamino group including two substituted or unsubstituted aryl groups each having 6 to 13 carbon atoms, a substituted or unsubstituted aryl group having 6 to 13 carbon atoms, an alkyl group having 1 to 7 carbon atoms, a substituted or unsubstituted monocyclic saturated hydrocarbon group having 3 to 20 carbon atoms, or a substituted or unsubstituted polycyclic saturated hydrocarbon group having 7 to 10 carbon atoms. The two aryl groups of the diarylamino group may be the same or different.